-
Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool
Mar 10, 2025, 14:00 PM -
Retrospective Real-World Study Assessing Treatment Patterns of Adult Patients with Moderate-to-Severe Psoriasis in the United States Initiating Advanced Therapies and Their Dispositions
Mar 10, 2025, 14:00 PM -
Trends in the Uptake of SGLT-2 Inhibitors in Type 2 Diabetes Mellitus With Comorbid Cardiovascular Conditions: A Longitudinal Analysis
Mar 10, 2025, 14:00 PM -
Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization (HCRU) and Economic Burden Among Patients With High-Risk Carcinoma-In-Situ (CIS) Non-Muscle Invasive Bladder Cancer (NMIBC) Using a Large Medicare Dataset
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Pembrolizumab for Previously treated MSI-H/dMMR Solid Tumors in Canada
Mar 10, 2025, 14:00 PM -
Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab
Mar 10, 2025, 14:00 PM -
Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Cardiovascular Hospitalization Events in Colombia
Mar 10, 2025, 14:00 PM -
Acute Care visits and Readmissions Among Commercial Plan Enrollees with Heart Failure with Preserved Ejection Fraction (HFpEF) by Obesity Classes
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors
Mar 10, 2025, 14:00 PM -
Developing a Value Assessment Framework for Modified New Drugs In China
Mar 10, 2025, 14:00 PM -
Real-World Disease Management Costs for U.S. Patients With Muscle Invasive Bladder Cancer (MIBC) Following Radical Cystectomy (RC) in Contemporary Practice
Mar 10, 2025, 14:00 PM -
Review of US Cost Effectiveness Evaluations for Antibody Drug Conjugates (ADCs) in Oncology
Mar 10, 2025, 14:00 PM -
A Large Language Model Approach for Evaluating Real-World Evidence in FDA Approvals
Mar 10, 2025, 14:00 PM -
Self-Reported Health-Related Quality-of-Life in Adolescent Patients with Complex Chronic Health Conditions from A Longitudinal Registry Study in Los Angeles County
Mar 10, 2025, 14:00 PM -
Meta-analysis of Economic Evaluations of Higher-Valent Pneumococcal Conjugate Vaccines For Seniors in High-Income Countries
Mar 10, 2025, 14:00 PM -
Late-Stage Outcomes in Patients with Limb-Girdle Muscular Dystrophy (LGMD) Sarcoglycanopathy Subtypes: A Systematic Review
Mar 10, 2025, 14:00 PM -
Patient Perspectives on Communication With Clinicians: A Survey on Hospitalized Patient Experiences
Mar 10, 2025, 14:00 PM -
Linkage Of Patient Services and Real-world Healthcare Data: A Unique Approach to Gain Insights into Factors that Impact Medication Adherence
Mar 10, 2025, 14:00 PM